<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
12854-588-00
</NDCCode>
<PackageDescription>
54 SYRINGE in 1 CASE (12854-588-00) > 3 mL in 1 SYRINGE
</PackageDescription>
<NDC11Code>
12854-0588-00
</NDC11Code>
<ProductNDC>
12854-588
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Insulin Glargine
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20150225
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Sanofi-Aventis Deutschland GmbH
</LabelerName>
<SubstanceName>
INSULIN GLARGINE
</SubstanceName>
<StrengthNumber>
300
</StrengthNumber>
<StrengthUnit>
U/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20191231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>